JP2020531451A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020531451A5 JP2020531451A5 JP2020508562A JP2020508562A JP2020531451A5 JP 2020531451 A5 JP2020531451 A5 JP 2020531451A5 JP 2020508562 A JP2020508562 A JP 2020508562A JP 2020508562 A JP2020508562 A JP 2020508562A JP 2020531451 A5 JP2020531451 A5 JP 2020531451A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- desb29
- insulin
- gglu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022071578A JP2022105082A (ja) | 2017-08-17 | 2022-04-25 | 新規のアシル化インスリン類似体およびそれらの使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17186612.2 | 2017-08-17 | ||
| EP17186612 | 2017-08-17 | ||
| EP17204872.0 | 2017-12-01 | ||
| EP17204872 | 2017-12-01 | ||
| PCT/EP2018/072191 WO2019034726A1 (en) | 2017-08-17 | 2018-08-16 | NOVEL ACYLATED INSULIN ANALOGUES AND USES THEREOF |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022071578A Division JP2022105082A (ja) | 2017-08-17 | 2022-04-25 | 新規のアシル化インスリン類似体およびそれらの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020531451A JP2020531451A (ja) | 2020-11-05 |
| JP2020531451A5 true JP2020531451A5 (enExample) | 2021-02-25 |
Family
ID=63165388
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020508562A Withdrawn JP2020531451A (ja) | 2017-08-17 | 2018-08-16 | 新規のアシル化インスリン類似体およびそれらの使用 |
| JP2022071578A Withdrawn JP2022105082A (ja) | 2017-08-17 | 2022-04-25 | 新規のアシル化インスリン類似体およびそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022071578A Withdrawn JP2022105082A (ja) | 2017-08-17 | 2022-04-25 | 新規のアシル化インスリン類似体およびそれらの使用 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US10919949B2 (enExample) |
| EP (1) | EP3668892A1 (enExample) |
| JP (2) | JP2020531451A (enExample) |
| KR (1) | KR20200038502A (enExample) |
| CN (1) | CN111032685A (enExample) |
| AU (1) | AU2018317810A1 (enExample) |
| BR (1) | BR112020002364A2 (enExample) |
| CA (1) | CA3071686A1 (enExample) |
| CL (1) | CL2020000310A1 (enExample) |
| CO (1) | CO2020002500A2 (enExample) |
| IL (1) | IL272394A (enExample) |
| MA (1) | MA49896A (enExample) |
| MX (1) | MX2020001434A (enExample) |
| PE (1) | PE20211264A1 (enExample) |
| PH (1) | PH12020550050A1 (enExample) |
| RU (1) | RU2020108281A (enExample) |
| SG (1) | SG11202001077UA (enExample) |
| TW (1) | TW201917134A (enExample) |
| WO (1) | WO2019034726A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1969004B1 (en) | 2005-12-28 | 2011-08-10 | Novo Nordisk A/S | Compositions comprising an acylated insulin and zinc and method of making the said compositions |
| US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
| CN114096269B (zh) | 2019-07-12 | 2024-06-11 | 诺和诺德股份有限公司 | 高浓度胰岛素制剂 |
| KR20240118914A (ko) | 2021-01-20 | 2024-08-05 | 바이킹 테라퓨틱스 인코포레이티드 | 대사 및 간 질환 치료를 위한 조성물 및 방법 |
| CA3231953A1 (en) | 2021-09-15 | 2023-03-23 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| JPWO2024185897A1 (enExample) * | 2023-03-09 | 2024-09-12 |
Family Cites Families (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE50892B1 (en) | 1980-02-11 | 1986-08-06 | Novo Industri As | Process for preparing insulin esters |
| DK58285D0 (da) | 1984-05-30 | 1985-02-08 | Novo Industri As | Peptider samt fremstilling og anvendelse deraf |
| PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| US5616729A (en) | 1986-07-17 | 1997-04-01 | Board Of Governors Of Wayne State University | Enhanced chemiluminescence from 1,2-dioxetanes through energy transfer to tethered fluorescers |
| DK105489D0 (da) | 1989-03-03 | 1989-03-03 | Novo Nordisk As | Polypeptid |
| DK155690D0 (da) | 1990-06-28 | 1990-06-28 | Novo Nordisk As | Nye peptider |
| DK10191D0 (da) | 1991-01-22 | 1991-01-22 | Novo Nordisk As | Hidtil ukendte peptider |
| DK33591D0 (enExample) | 1991-02-27 | 1991-02-27 | Novo Nordisk As | |
| ZA954983B (en) | 1994-06-17 | 1996-02-14 | Novo Nordisk As | N-terminally extended proteins expressed in yeast |
| US6500645B1 (en) | 1994-06-17 | 2002-12-31 | Novo Nordisk A/S | N-terminally extended proteins expressed in yeast |
| US5693609A (en) | 1994-11-17 | 1997-12-02 | Eli Lilly And Company | Acylated insulin analogs |
| US6451970B1 (en) | 1996-02-21 | 2002-09-17 | Novo Nordisk A/S | Peptide derivatives |
| ATE317443T1 (de) | 1996-12-20 | 2006-02-15 | Novo Nordisk As | N-terminal verlängerte proteine exprimiert in hefe |
| JP2002535287A (ja) | 1999-01-26 | 2002-10-22 | イーライ・リリー・アンド・カンパニー | 単分散性６量体のアシル化されたインスリンアナログ製剤 |
| CA2372393A1 (en) | 1999-05-19 | 2000-11-23 | Bassil I. Dahiyat | Novel proteins with insulin-like activity useful in the treatment of diabetes |
| RU2283846C2 (ru) | 1999-12-29 | 2006-09-20 | Ново Нордиск А/С | Предшественник инсулина, способ его получения и применение |
| ES2369895T3 (es) | 2003-12-03 | 2011-12-07 | Novo Nordisk A/S | Insulina monocatenaria. |
| WO2006008238A1 (en) * | 2004-07-16 | 2006-01-26 | Novo Nordisk A/S | Method for selective acylation |
| WO2006082204A1 (en) | 2005-02-02 | 2006-08-10 | Novo Nordisk A/S | Insulin derivatives |
| JP5202338B2 (ja) | 2006-02-27 | 2013-06-05 | ノボ・ノルデイスク・エー／エス | 新規インシュリン誘導体 |
| CN101541830A (zh) | 2006-09-22 | 2009-09-23 | 诺沃-诺迪斯克有限公司 | 蛋白酶抗性的胰岛素类似物 |
| AU2008288413B2 (en) | 2007-08-15 | 2013-09-26 | Novo Nordisk A/S | Insulin analogues with an acyl and aklylene glycol moiety |
| CN101970477B (zh) | 2008-03-14 | 2014-12-31 | 诺沃-诺迪斯克有限公司 | 蛋白酶稳定的胰岛素类似物 |
| HUE032284T2 (en) * | 2008-03-18 | 2017-09-28 | Novo Nordisk As | Protease-stabilized, acylated insulin analogues |
| US8697632B2 (en) | 2008-12-19 | 2014-04-15 | Indiana University Research And Technology Corporation | Amide based insulin prodrugs |
| EP2376099A4 (en) | 2008-12-19 | 2012-04-25 | Univ Indiana Res & Tech Corp | INSULIN AGAIN YL-BASED GROWTH FACTORS WITH HIGH ACTIVITY AT THE INSULIN RECEPTOR |
| JP5789515B2 (ja) | 2008-12-19 | 2015-10-07 | インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ | インスリン類似体 |
| WO2011003820A1 (de) | 2009-07-06 | 2011-01-13 | Sanofi-Aventis Deutschland Gmbh | Hitze- und schüttelstabile insulinzubereitungen |
| WO2011159882A2 (en) | 2010-06-16 | 2011-12-22 | Indiana University Research And Technology Corporation | Novel stabilized insulin agonists |
| JP5969469B2 (ja) | 2010-06-16 | 2016-08-17 | インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ | インスリン受容体に対して高い活性を示す単鎖インスリンアゴニスト |
| EP2585484A1 (en) | 2010-06-23 | 2013-05-01 | Novo Nordisk A/S | Insulin analogues containing additional disulfide bonds |
| WO2011163460A1 (en) | 2010-06-24 | 2011-12-29 | Indiana University Research And Technology Corporation | Yl-based insulin-like growth factors exhibiting high activity at the insulin receptor |
| CA2803164C (en) | 2010-06-24 | 2018-08-21 | Indiana University Research And Technology Corporation | Amide-based insulin prodrugs |
| JP2013535467A (ja) | 2010-07-28 | 2013-09-12 | スマートセルズ・インコーポレイテツド | 組換えにより発現されたインスリンポリペプチドおよびその使用 |
| JP2013540771A (ja) | 2010-10-15 | 2013-11-07 | ノヴォ ノルディスク アー／エス | 新規ｎ末端修飾インスリン誘導体 |
| AR087433A1 (es) | 2011-08-08 | 2014-03-26 | Merck Sharp & Dohme | Analogos de insulina n-glicosilados |
| CN104114183A (zh) | 2011-12-20 | 2014-10-22 | 印第安纳大学研究及科技有限公司 | 用于治疗糖尿病的基于ctp的胰岛素类似物 |
| WO2013093009A1 (en) | 2011-12-21 | 2013-06-27 | Novo Nordisk A/S | N -terminally modified insulin derivatives |
| CN108383902A (zh) | 2012-09-26 | 2018-08-10 | 印第安纳大学研究及科技有限公司 | 胰岛素类似物二聚体 |
| EP2925345B1 (en) | 2012-12-03 | 2018-09-05 | Merck Sharp & Dohme Corp. | Method for making o-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues |
| US10421795B2 (en) | 2012-12-17 | 2019-09-24 | Merck Sharp & Dohme Corp. | Process for purifying insulin and analogues thereof |
| JP6538645B2 (ja) | 2013-03-14 | 2019-07-03 | インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ | インスリン‐インクレチン複合物 |
| EP3024447A1 (en) | 2013-07-24 | 2016-06-01 | Novo Nordisk A/S | Pharmaceutical composition for oral insulin administration comprising a tablet core and an anionic copolymer coating |
| US9884125B2 (en) | 2013-10-04 | 2018-02-06 | Merck Sharp & Dohme Corp. | Glucose-responsive insulin conjugates |
| AR099569A1 (es) * | 2014-02-28 | 2016-08-03 | Novo Nordisk As | Derivados de insulina y los usos médicos de estos |
| CN108271356A (zh) | 2014-09-24 | 2018-07-10 | 印第安纳大学研究及科技有限公司 | 肠降血糖素-胰岛素缀合物 |
| EP3197912B1 (en) | 2014-09-24 | 2023-01-04 | Indiana University Research & Technology Corporation | Lipidated amide-based insulin prodrugs |
| AU2015349890B2 (en) | 2014-11-21 | 2018-08-30 | Merck Sharp & Dohme Llc | Insulin receptor partial agonists |
| JP6737793B2 (ja) | 2015-01-29 | 2020-08-12 | ノヴォ ノルディスク アー／エス | 錠剤コアとポリビニルアルコールコーティングとを含む経口インスリン投与のための医薬組成物 |
| EP3268384B1 (en) | 2015-03-10 | 2021-11-03 | Merck Sharp & Dohme Corp. | Process for preparing recombinant insulin using microfiltration |
| EP3280450A4 (en) | 2015-04-08 | 2018-12-12 | Merck Sharp & Dohme Corp. | Glucose-responsive insulin conjugates |
| WO2016172269A2 (en) | 2015-04-20 | 2016-10-27 | University Of Utah Research Foundation | Insulin analogs having shortened b chain peptides and associated methods |
| EP3341401A1 (en) * | 2015-08-25 | 2018-07-04 | Novo Nordisk A/S | Novel insulin derivatives and the medical uses hereof |
| CN108368163A (zh) * | 2015-08-25 | 2018-08-03 | 诺和诺德股份有限公司 | 新型胰岛素衍生物及其医学用途 |
| BR112018002416A2 (pt) | 2015-08-25 | 2018-09-18 | Novo Nordisk As | derivados de insulina e seus usos médicos |
| WO2017040363A1 (en) | 2015-09-02 | 2017-03-09 | Merck Sharp & Dohme Corp. | A process for obtaining insulin with correctly formed disulfide bonds |
-
2018
- 2018-08-16 CA CA3071686A patent/CA3071686A1/en not_active Withdrawn
- 2018-08-16 RU RU2020108281A patent/RU2020108281A/ru unknown
- 2018-08-16 TW TW107128618A patent/TW201917134A/zh unknown
- 2018-08-16 CN CN201880052683.1A patent/CN111032685A/zh not_active Withdrawn
- 2018-08-16 MA MA049896A patent/MA49896A/fr unknown
- 2018-08-16 JP JP2020508562A patent/JP2020531451A/ja not_active Withdrawn
- 2018-08-16 SG SG11202001077UA patent/SG11202001077UA/en unknown
- 2018-08-16 US US15/998,755 patent/US10919949B2/en active Active
- 2018-08-16 MX MX2020001434A patent/MX2020001434A/es unknown
- 2018-08-16 AU AU2018317810A patent/AU2018317810A1/en not_active Withdrawn
- 2018-08-16 EP EP18752779.1A patent/EP3668892A1/en not_active Withdrawn
- 2018-08-16 KR KR1020207006535A patent/KR20200038502A/ko not_active Withdrawn
- 2018-08-16 WO PCT/EP2018/072191 patent/WO2019034726A1/en not_active Ceased
- 2018-08-16 PE PE2020000179A patent/PE20211264A1/es unknown
- 2018-08-16 BR BR112020002364-7A patent/BR112020002364A2/pt not_active Application Discontinuation
-
2020
- 2020-01-31 IL IL272394A patent/IL272394A/en unknown
- 2020-02-05 CL CL2020000310A patent/CL2020000310A1/es unknown
- 2020-02-07 PH PH12020550050A patent/PH12020550050A1/en unknown
- 2020-03-04 CO CONC2020/0002500A patent/CO2020002500A2/es unknown
- 2020-11-05 US US17/089,993 patent/US20210094999A1/en not_active Abandoned
-
2022
- 2022-04-25 JP JP2022071578A patent/JP2022105082A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2020108281A (ru) | Новые ацилированные аналоги инсулина и варианты их применения | |
| JP2013514323A5 (enExample) | ||
| JP2012506402A5 (enExample) | ||
| JP7484018B2 (ja) | Ｇｌｐ－１プロドラッグおよびその使用 | |
| US10265384B2 (en) | Tablets comprising GLP-1 agonist and enteric coating | |
| JP2013523619A5 (enExample) | ||
| JP2017105819A5 (enExample) | ||
| JP2012509846A5 (enExample) | ||
| ES2530235T3 (es) | Compuestos para el tratamiento de trastornos metabólicos | |
| JP2018505859A5 (enExample) | ||
| JP2009535393A5 (enExample) | ||
| JP2010529203A5 (enExample) | ||
| CN107205949A (zh) | 包含片芯和立即释放包衣的用于口服glp‑1给药的药物组合物 | |
| JP7432361B2 (ja) | ヒトインスリンまたはそのアナログのアシル化誘導体 | |
| EP2544536A1 (en) | Fatty acid conjugates of quetiapine, process for making and using the same | |
| JP2009536178A5 (enExample) | ||
| JP2010538049A5 (enExample) | ||
| WO2013166176A1 (en) | Fatty acid conjugates of statin and fxr agonists; compositions and method of uses | |
| JP2006515838A5 (enExample) | ||
| RU2001122114A (ru) | 4-(гетероциклилсульфонамидо)-5-метокси-6-(2-метоксифенокси)-2-фенил- или пиридилпиримидины в качестве антагонистов рецептора эндотелина | |
| JP5172911B2 (ja) | 癒着の予防及び／又は治療のための医薬 | |
| US20100274022A1 (en) | G protein-coupled receptor inhibitor and pharmaceutical product | |
| CN1956735A (zh) | 用于增强治疗剂黏膜吸收的递送剂 | |
| JP2024521757A5 (enExample) | ||
| CN101607979A (zh) | 五环三萜-维生素c缀合物、其制备方法及其医药用途 |